Malignant hematopoietic disease with the indication of an hematopoietic stem cell transplantation.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Maliginant hematopoietic disease with the indication of a HSCT 2.Patients aged 20 years or more 3.Good Japanese language skills 4.The written consent of the patient
Exclusion criteria
Exclusion criteria: 1.Recent cardiovascular or pulmonary disease 2.Karnofsky performance scale 40% or less
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of posttransplant hospitalization | — |
Countries
Japan
Contacts
Kyoto University Human Health Science, Graduate School of Medicine